Tel : 0086-021-5165-9050 / 0086-15618223367 Email : sales@atkchmemical.com
GSK2983559
ATK-18720
98.00%
1579965-12-0
C21H23N4O7PS2
538.5336830616
Article number Size Operate
ATK-18720 10MG 10MG Inquiry
ATK-18720 20MG 20MG Inquiry
Detection information
Purity: 99.99%
Product Details
CAS Number 1579965-12-0 Appearance
Catalog NO ATK-18720 MDL Number
Molecular Formula C21H23N4O7PS2 Molecular Weight 538.5336830616
Boiling Point Melting Point
Flash Poin Density
Synonyms 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate;GSK2983559 (free acid);2-[4-(1,3-benzothiazol-5-ylamino)-6-~{tert}-butylsulfonyl-quinazolin-7-yl]oxyethyl dihydrogen phosphate;RIPK2 inhibitor 3;GTPL10413;BCP23871;compound 3 [PMID: 31265286];Example 1 [WO2014043446A1];K9T;2-[4-(1,3-benzothiazol-5-ylamino)-6-tert-butylsulfonylquinazolin-7-yl]oxyethyl dihydrogen phosphate;Ethanol, 2-[[4-(5-benzot;CID 73386708;GSK2983559 free acid;GSK2983559 (compound 3);s8927;compound 3 [PMID:;WJY2LV4368;2-{[4-(1,3-benzothiazol-5-ylamino)-6-(2-methylpropane-2-sulfonyl)quinazolin-7-yl]oxy}ethoxyphosphonic acid;Ethanol, 2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-, 1-(dihydrogen phosphate);GSK-2983559; GSK 2983559;1579965-12-0;CS-0042468;AC-36438;2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-ethanol, 1-(dihydrogen phosphate);AKOS030527989;EX-A3446;SCHEMBL15578200;GSK-2983559;GSK2983559?;GSK-2983559 free acid;BDBM50405272;GSK2983559;CHEMBL4596287;HY-112038;[2-({4-[(1,3-benzothiazol-5-yl)amino]-6-(2-methylpropane-2-sulfonyl)quinazolin-7-yl}oxy)ethoxy]phosphonic acid;MFCD30489430
Storage Condition
Safety
GHS Pictogram
Signal Word UN Number
Hazard Statements Class
Precautionary Statements Packing Group
Description
There is currently no product overview available!